Yingu Pharmaceutical Co., Ltd.
Records under this name other than the patents Yingu Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 5 of 5 · Back to Yingu Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,207,192 | Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine Term ended Term ended Mar 8, 2026 · USPTO record | Term ended | Term ended Mar 8, 2026 | USPTO record |
| US 7,521,559 | Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine Term ended Term ended Apr 11, 2025 · USPTO record | Term ended | Term ended Apr 11, 2025 | USPTO record |
| US 8,394,824 | Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine Term ended Ended no later than Sep 15, 2024 · USPTO record | Term ended | Ended no later than Sep 15, 2024 | USPTO record |
| US 8,673,981 | Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof Lapsed on the fee record Ended Mar 18, 2022 · USPTO record | Lapsed on the fee record | Ended Mar 18, 2022 | USPTO record |
| US 8,497,305 | Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof Lapsed on the fee record Ended Jul 30, 2021 · USPTO record | Lapsed on the fee record | Ended Jul 30, 2021 | USPTO record |